Zobrazeno 1 - 10 of 11 pro vyhledávání: '"Katsuyoshi Kawazoe"'
1
EFFECTS OF A 2-SUBSTITUTED ADENOSINE DERIVATIVE, 2-(P-METHOXYPHENYL)-ADENOSINE (CV-1674) ON CORONARY AND CARDIOHEMODYNAMICS, AND MYOCARDIAL ENERGETICS
Autor: Katsuyoshi Kawazoe, Minoru Hirata, Masao Tanabe, Kenzo Kikuchi
Publikováno v: Japanese Journal of Pharmacology. 27:689-700
In dogs, intracoronary doses of CV-1674, adenosine ( ADS) and 2-Cl-ADS for doubling coronary flow were estimated as 5.0, 2.0 and 0.4 microgram/dog, and i.v. doses 31, 71 and 2.5 microgram/kg, respectively. ADS and 2-Cl-ADS decreased, while CV-1674 in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4864009e16833e7beb4e05cf3d4e1e1b
https://doi.org/10.1254/jjp.27.689
Zobrazit plný text záznamu
4
Antihypertensive Action of a Non-Sulfhydryl Angiotensin Converting Enzyme Inhibitor (CV-3317) in Various Hypertensive Models
Autor: Kohei Nishikawa, Katsuyoshi Kawazoe, Masao Tanabe, Yoshiyuki Inada, Shintaro Kikuchi, Yumiko Shibouta
Publikováno v: Japanese Journal of Pharmacology. 42:1-8
The antihypertensive action of N-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-N-(indan-2-yl)glycine hydrochloride (CV-3317), a nonsulfhydryl compound characterized as an angiotensin converting enzyme inhibitor in our previous work, was examined
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fd93e7fa7c94317dc4357cf9a663364
https://doi.org/10.1254/jjp.42.1
Zobrazit plný text záznamu
6
CV-4151--a potent, selective thromboxane A2 synthetase inhibitor
Autor: Yoshimi Imura, K. Nishikawa, Katsuyoshi Kawazoe, Shinji Terao, Kaneyoshi Kato, Masao Tanabe, Zen-ichi Terashita
Publikováno v: Thrombosis research. 41(2)
(E)-7-Phenyl-7-(3-pyridyl)-6-heptenoic acid (CV-4151) inhibited horse platelet crosomal thromboxane (TX) A2synthetase with an IC50 of 2.6 × 10−8 M, but even at a high concentration of 10−4 M it had little effect on cyclooxygenase, PGI2 synthetas
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd7bf938567dccfa820e1b4971e7794c
https://pubmed.ncbi.nlm.nih.gov/3083523
Zobrazit plný text záznamu
7
Effect of 2-phenylaminoadenosine (CV-1808) on ischemic ST-segment elevation in anesthetized dogs
Autor: Katsuyoshi Kawazoe, Minoru Hirata, Naohiko Matsumoto, Shuji Fujiwara, Masao Tanabe, Tetsuji Imamoto
Publikováno v: Journal of cardiovascular pharmacology. 3(6)
The effect of 2-phenylaminoadenosine (CV-1808) against myocardial ischemia was studied in anesthetized dogs. During intravenous infusion of CV-1808 (0.25 and 0.5 microgram/kg/min for 10 min) the ST-segment elevation in the epicardial ECG induced by a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4cce1bd02c75cf80e44b0d54838e7a9
https://pubmed.ncbi.nlm.nih.gov/6173517
Zobrazit plný text záznamu
8
Angiotensin converting enzyme inhibitory activity and antihypertensive action of CV-3317
Autor: Yoshiyuki Inada, Zen-ichi Terashita, Masao Tanabe, Katsuyoshi Kawazoe, Yoshikazu Oka, Kohei Nishikawa, Shintaro Kikuchi
Publikováno v: Japanese Journal of Pharmacology. 33:273
Recent clinical data demonstrate that angiotensin converting enzyme (ACE) inhibitors possess promising antihypertensive properties. We now report on the ACE inhibitory activity and antihypertensive action of N-[N-[1-(S)-ethoxycarbonyl-3-pheny1propy1]
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1fbfdc0cc2f8d9f72a6d336c1d14c23a
https://doi.org/10.1016/s0021-5198(19)64875-4
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje